Coordination and technical support
Ended Awarded Last action
- Contract number
- HHSN27200001
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,641,780
Award facts
- Opportunity
-
- NIHAI2014013 Solicitation number
- Contract value 35% obligated
-
- $1,641,780.00 Current, with exercised options
- $4,687,192.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$220,027 | |
| Funding Only Action | -$372,906 | |
| Exercise an Option | $747,853 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $742,765 | |
| Original award | $744,095 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the International AIDS Vaccine Initiative (IAVI), a non-profit organization. The contract has a total ceiling value of $4,687,192.00 and is a delivery order under IAVI's existing indefinite delivery/indefinite quantity (IDIQ) contract with NIAID for preclinical services supporting the development of biopharmaceutical products, including vaccines, for infectious diseases. The contract provides coordination and technical support services and does not have a set-aside designation. IAVI serves as the prime contractor and may utilize subcontractors to provide specialized expertise. The contract supports IAVI's work in advancing the development of novel vaccine candidates, particularly for HIV and tuberculosis, through preclinical and clinical testing.
Quick answers
Who was awarded contract HHSN27200001?
HHSN27200001 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 14, 2016.
How much is contract HHSN27200001 worth?
The government has obligated $1,641,780 on HHSN27200001. Its potential value, with all options, is $4,687,192.
Is contract HHSN27200001 an order under another contract?
Yes. HHSN27200001 is a delivery order under HHSN272201600011I, an indefinite delivery contract.
Was contract HHSN27200001 competed?
The extent of competition for HHSN27200001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award